Download Files:
Products Details
Product Description
– AKT-IN-9 is a potent inhibitor of AKT. Protein kinase B (PKB, also known as AKT) is central to PI3K/AKT/mTOR signaling in cells, and its function is important for cell growth, survival, differentiation and metabolism. AKT-IN-9 has the potential for the research of breast and prostate cancer (extracted from patent WO2021185238A1, compound 1)[1].
Web ID
– HY-144059
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C24H29ClN6O
References
– [1]Xin Li, et al. Thickened dicyclic derivatives, their preparation methods and their application in medicine. Patent WO2021185238A1.
CAS Number
– 2709045-53-2
Molecular Weight
– 452.98
SMILES
– CC(C)NC[C@H](C1=CC=C(C=C1)Cl)C(N2C3CN(C4=C5C(NC=C5)=NC=N4)CC2CC3)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Akt
Pathway
– PI3K/Akt/mTOR
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
